Barbier, Olivier

Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans

Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., & Chouinard, S. (2003) · Trends in Endocrinology & Metabolism

Pharmacogenetics and Drug MetabolismProstate Cancer Treatment and Research

Cited by 235

UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells

Chouinard, S., Barbier, O., & Bélanger, A. (2007) · Journal of Biological Chemistry

Prostate Cancer Treatment and ResearchPharmacogenetics and Drug Metabolism

Cited by 109

Inactivation by UDP-glucuronosyltransferase enzymes: The end of androgen signaling

Chouinard, S., Yueh, M.-F., Tukey, R. H., Giton, F., Fiet, J., Pelletier, G., Barbier, O., & Bélanger, A. (2008) · The Journal of Steroid Biochemistry and Molecular Biology

Pharmacogenetics and Drug MetabolismProstate Cancer Treatment and Research

Cited by 90

Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution

Gauthier-Landry, L., Bélanger, A., & Barbier, O. (2015) · The Journal of Steroid Biochemistry and Molecular Biology

Prostate Cancer Treatment and ResearchPharmacogenetics and Drug Metabolism

Cited by 62

The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis

Mouchiroud, M., Camiré, É., Aldow, M., Caron, A., Jubinville, É., Turcotte, L., Kaci, I., Beaulieu, M.-J., Roy, C., Labbé, S. M., et al. (2019) · JCI Insight

Liver Disease Diagnosis and TreatmentCholesterol and Lipid Metabolism

Cited by 57

Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites

Girard, C., Barbier, O., Veilleux, G., El-Alfy, M., & Bélanger, A. (2003) · Endocrinology

Pharmacogenetics and Drug MetabolismHormonal Regulation and Hypertension

Cited by 45

PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases

Gallucci, G. M., Hayes, C. M., Boyer, J. L., Barbier, O., Assis, D. N., & Ghonem, N. S. (2024) · Cells

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 40

PPARα L162V polymorphism alters the potential of n‐3 fatty acids to increase lipoprotein lipase activity

Rudkowska, I., Caron‐Dorval, D., Verreault, M., Couture, P., Deshaies, Y., Barbier, O., & Vohl, M. (2010) · Molecular Nutrition & Food Research

Fatty Acid Research and HealthLipid metabolism and disorders

Cited by 36

Adjunct Fenofibrate Up‐regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis

Gallucci, G. M., Trottier, J., Hemme, C., Assis, D. N., Boyer, J. L., Barbier, O., & Ghonem, N. S. (2021) · Hepatology Communications

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 26

The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis

Mouchiroud, M., Camiré, É., Aldow, M., Caron, A., Jubinville, É., Turcotte, L., Kaci, I., Beaulieu, M.-J., Roy, C., Labbé, S. M., et al. (2019) · Molecular Metabolism

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 24